miRNA screening through nipple aspiration sampling

Towards deciphering the functional genetics and neo-antigenic landscape in melanoma

Polycomb repressors and epigenetic therapy

DNA repair and mutations as targets for personalised therapy

The changing process of drug discovery and design

Glioblastoma heterogeneity in circulating tumour DNA

Obesity promotes pancreatic cancer progression and resistance

Connections in cancer-host immune signalling

Targeting and imaging invasion and metastasis

ERß expression predicts breast cancer risk in hyperplasia

Advances in early detection

Polygenic risk and the targeted prevention of cancer

Regulation of T cells in tissues and tumours

Physical pressure of tumour on healthy cells induces oncogenes

Understanding mutational processes in human cancer

ß1 integrins and DNA repair for radiosensitization of head and neck cancer

Mouse models of lung cancer

'Rewiring' tumour susceptibility

Deciphering RAS/MAPK signalling in cancer